Glycemic Variability and Insulin Needs in Patients with Type 1 Diabetes Mellitus Supplemented with Vitamin D: A Pilot Study Using Continuous Glucose Monitoring System

Title:Glycemic Variability and Insulin Needs in Patients with Type 1 Diabetes Mellitus Supplemented with Vitamin D: A Pilot Study Using Continuous Glucose Monitoring System

Volume: 14 Issue: 4

Author(s): Karem Mileo Felício, Ana Carolina Contente Braga de Souza, Joao Felicio Abrahao Neto, Franciane Trindade Cunha de Melo, Carolina Tavares Carvalho, Thais Pontes Arbage, Hana Andrade de Rider Brito, Amanda Soares Peixoto, Alana Ferreira de Oliveira, Fabricio de Souza Resende, Scarlatt Sousa Reis, Ana Regina Motta, Henrique da Costa Miranda, Luisa Correa Janau, Elizabeth Sumi Yamada and Joao Soares Felicio*

Affiliation:

• University Hospital Joao de Barros Barreto, Federal University of Para, Endocrinology Division, Mundurucus Street, 4487, Guama, Belem, Para, 66073-000,Brazil

Keywords: Type 1 diabetes mellitus, vitamin D supplementation, glycemic variability, insulin resistance, glucose, insulin.

Abstract: Background: Recent studies suggest that glycemic variability could influence the risk of complications in Type 1 Diabetes Mellitus (T1DM). There are no data about the action of Vitamin D (VD) on glycemic variability. Our pilot study aims to evaluate glycemic variability and insulin needs in patients with T1DM supplemented with VD.

Methods: 22 Patients received doses of 4000 and 10000 IU/day of cholecalciferol for 12 weeks, according to the patient’s baseline VD levels and underwent continuous glucose monitoring system.

Results: Correlations were found between percentage variation (Δ) of glycemia standard deviation (ΔSDG), calculated using continuous glucose monitoring, with Δ of basal (r = 0.6; p <0.01) and total insulin dose (r = 0.6; p <0.01). Correlations between VD status after supplementation and Δ of prandial (r = 0.5; p <0.05) and total insulin dose (r = 0.4; p <0.05) were found, suggesting that the dose of insulin needed by patients is lower when VD status is better. We divided patients in two subgroups: SDG improved (subgroup 1; N = 12 (55%)) and SDG worsened (subgroup 2; N = 10 (45%)). Group 1, compared to subgroup 2, required a lower insulin dose (Δbasal insulin dose = -8.0 vs. 6.3%; p <0.05) and had a lower frequency of hypoglycemia (27% vs. 64%, hypoglycemias/days evaluated; p <0.01).

Conclusion: Our study suggests a relation between VD supplementation, improved glycemic variability, lower insulin needs and lower frequency of hypoglycemia in patients with T1DM.

Cite this article as:

Felício Mileo Karem , de Souza Carolina Contente Braga Ana , Neto Felicio Abrahao Joao, de Melo Trindade Cunha Franciane, Carvalho Tavares Carolina , Arbage Pontes Thais , de Rider Brito Andrade Hana , Peixoto Soares Amanda , de Oliveira Ferreira Alana , de Souza Resende Fabricio , Reis Sousa Scarlatt , Motta Regina Ana , da Costa Miranda Henrique, Janau Correa Luisa , Yamada Sumi Elizabeth and Felicio Soares Joao *, Glycemic Variability and Insulin Needs in Patients with Type 1 Diabetes Mellitus Supplemented with Vitamin D: A Pilot Study Using Continuous Glucose Monitoring System, Current Diabetes Reviews 2018; 14 (4) . https://dx.doi.org/10.2174/1573399813666170616075013